Literature DB >> 6491005

Why do melanomas ulcerate?

J M Mascaro, J Castro, T Castel, M Lecha, R Gratacos, J M Mascaro.   

Abstract

Ulceration is an indicator of unfavourable prognosis in malignant melanoma (MM). But why do melanomas ulcerate?. Possible causes of ulceration were investigated in a group of 69 ulcerated and 69 non-ulcerated malignant melanomas. A significant correlation (P less than 0.001) between ulceration and mitotic index was found. In a group of 69 ulcerated malignant melanomas, 49 had over 7, 15 had 4-6, and only 5 had 0-3 mitotic figures per 10 high-power fields. Among 69 non-ulcerated melanomas, 28 had more than 7, 24 had 4-6, and 17 had 0-3 mitotic figures per 10 high-power fields. This study supports the hypothesis that ulceration of melanomas is usually the result of the destruction of the epidermis by the proliferating neoplastic cells or modification of blood supply due to the expansile activity of the tumor. The relationship between ulceration and mitotic activity helps clarify the prognostic significance of ulceration.

Entities:  

Mesh:

Year:  1984        PMID: 6491005     DOI: 10.1111/j.1600-0560.1984.tb00377.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  4 in total

1.  Prognostic parameters for the primary care of melanoma patients: what is really risky in melanoma?

Authors:  Daniela Göppner; Martin Leverkus
Journal:  J Skin Cancer       Date:  2011-10-11

2.  A retrospective study of malignant melanoma from a tertiary care centre in Saudi Arabia from 2004 to 2016.

Authors:  A Alshedoukhy; P Cahusac; J Kashir; F H Alkhawaja; A M M Tulbah; K Anwar
Journal:  Clin Transl Oncol       Date:  2019-06-29       Impact factor: 3.340

3.  Biology of human cutaneous melanoma.

Authors:  Elias G Elias; Joanne H Hasskamp; Bhuvnesh K Sharma
Journal:  Cancers (Basel)       Date:  2010-03-12       Impact factor: 6.639

4.  Peritumoral Immune Infiltrate as a Prognostic Biomarker in Thin Melanoma.

Authors:  Francesco Sabbatino; Giosuè Scognamiglio; Luigi Liguori; Antonio Marra; Anna Maria Anniciello; Giovanna Polcaro; Jessica Dal Col; Alessandro Caputo; Anna Lucia Peluso; Gerardo Botti; Pio Zeppa; Soldano Ferrone; Stefano Pepe
Journal:  Front Immunol       Date:  2020-09-29       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.